- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0783 - Cellules TCellules NKProgéniteurs de cellules T ou NK
Détention brevets de la classe C12N 5/0783
Brevets de cette classe: 12398
Historique des publications depuis 10 ans
|
474
|
639
|
846
|
932
|
1069
|
1239
|
1126
|
1216
|
1211
|
337
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1122 |
664 |
| Iovance Biotherapeutics, Inc. | 364 |
273 |
| The Regents of the University of California | 20534 |
254 |
| The Trustees of the University of Pennsylvania | 4403 |
225 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2968 |
153 |
| Board of Regents, The University of Texas System | 6031 |
151 |
| Cellectis | 410 |
135 |
| Memorial Sloan-Kettering Cancer Center | 1999 |
129 |
| Baylor College of Medicine | 993 |
114 |
| Juno Therapeutics, Inc. | 486 |
114 |
| The Board of Trustees of the Leland Stanford Junior University | 6594 |
104 |
| Immunitybio, Inc. | 494 |
104 |
| Novartis AG | 10346 |
102 |
| City of Hope | 1016 |
94 |
| Kite Pharma, Inc. | 433 |
90 |
| Autolus Limited | 265 |
87 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1007 |
85 |
| Regents of the University of Minnesota | 2765 |
79 |
| FATE Therapeutics, Inc. | 226 |
76 |
| Takeda Pharmaceutical Company Limited | 2718 |
75 |
| Autres propriétaires | 9290 |